UCL  IRIS
Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at https://www.ucl.ac.uk/finance/research/rs-contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
 More search options
Prof Mike Ehrenstein
Room 418
Rayne Building
5 University Street
London
WC1E 6JF
Prof Mike Ehrenstein profile picture
Appointment
  • Professor of Experimental Rheumatology
  • Inflammation
  • Div of Medicine
  • Faculty of Medical Sciences
Biography

Michael Ehrenstein is Professor of Experimental Rheumatology at University College London (UCL) and Honorary Consultant Rheumatologist at University College London Hospitals (1999-). From 1996-1999 he was an MRC Clinician Scientist at the Laboratory of Molecular Biology in Cambridge with Michael Neuberger FRS and Honorary Consultant Rheumatologist at Addenbrooke's Hospital. He obtained his PhD in 1994 at UCL on the topic of autoantibodies in systemic lupus erythematosus. He trained in medicine at the Middlesex Hospital Medical School.


Research Groups
Research Themes
Research Summary

My research group focusses on translational research in patients with autoimmune rheumatic disease. Our most recent achievement has been the BEAT-lupus trial testing the combination of the anti-BAFF therapeutic belimumab given after rituximab for patients with systemic lupus erythematous (SLE). We are now studying the immune consequences of this combination therapy to identify mechanisms of disease and biomarkers of response to therapy in SLE. Novel biologic therapies can be used as a tool to understand and manipulate the aberrant immune responses found in patients with autoimmunity. 

Other projects include:

1. The balance between pro-inflammatory (e.g. Th17) and regulatory T cell subsets in patients with rheumatoid arthritis and how we can alter this balance in favour of tolerance.

2. The effects of anti-TNF therapy on regulatory T cells in patients with rheumatoid arthritis and whether this could be used to develop clinical biomarkers.


 







Academic Background
1994   Doctor of Philosophy University College London
Some IRIS profile information is sourced from HR data as explained in our FAQ. Please report any queries concerning HR data shown on this page to hr-services@ucl.ac.uk.
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by